BWTBS - MORPHINE SULFATE INJ., U.S.P.

Product Identification

Product ID:MORPHINE SULFATE INJ., U.S.P.
MSDS Date:08/12/1985
FSC:6505
NIIN:01-230-6241
MSDS Number: BWTBS

Responsible Party
ABBOTT LABORATORIES,HOSPITAL PRODUCTS DIV
200 ABBOTT PARK RD
ABBOTT PARK, IL 60064-3537
US

Emergency Phone: 312-937-6100

Info Phone: 312-937-6100

Preparer: J. FAZE

Cage: 60060

Contractor
ABBOTT LABORATORIES INC
NORTH CHICAGO, IL 60064 US

Telephone: 847-935-7177

Cage: 60060

Ingredients

MORPHINE (SULFATE, PENTAHYDRATE)

CAS: 6211-15-0

RTECS: QC8760000


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Hazards

LD50 LC50 Mixture:LD50 (ORAL RAT) IS 461-905 MG/KG
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:CONTAINS MORPHINE SULFATE. HEALTH
RELATED DATA IS BASED ON MORPHINE SULFATE CONTENT. *PRODUCES
DEPENDENCY.* PROBABLE LETHAL DOSE=120-250 MG. TOXIC @ 60-100 MG.
ABSORBED VIA NASAL & RESPIRATORY MUCOSA. REPORTED TO BE MUTAGENIC
& TERATOGENIC.
Explanation of Carcinogenicity:MFR GAVE THE ABOVE LISTINGS ON THE MSDS
BUT NO OTHER COMMENTS WERE RECORDED.
Effects of Overexposure:SKIN:ITCHING, URTICARIA & BRONCHIAL SPASM VIA
HISTAMINE RELEASE. EYE:MIOSIS INDUCED, REDUCTION IN VISUAL FIELD,
BLURRED VISION. SYSTEMIC SYMPTOMS:ALTERED RESPIRATION, PINPOINT
PUPILS, NAUSEA, VOMITING , CONSTIPATION, URINE RETENTION, WEAK
PULSE, MUSCLE TWITCHING/SPASM, CYANOSIS, COMA, DEATH BY PARALYSIS.
Medical Cond Aggravated by Exposure:MFR GAVE NO INFORMATION ON MSDS.

First Aid

First Aid:IF INGESTED, MAINTAIN RESPIRATION & GET IMMEDIATE MEDICAL
ATTENTION. ADMINISTRATION OF A SPECIFIC NARCOTIC ANTAGONIST &
OBSERVATION FOR 24-48 HOURS ARE ADVISED.

Fire Fighting

Flash Point:NON-FLAMMABLE
Fire Fighting Procedures:NONE
Unusual Fire/Explosion Hazard:NONE

Accidental Release

Spill Release Procedures:ABSORB W/SUITABLE MATERIAL, FLUSH W/WATER.
Neutralizing Agent:MFR GAVE NO INFORMATION ON MSDS.

Handling

Handling and Storage Precautions:AVOID EXCESSIVE STORAGE TEMPERATURE &
PROTECT FORM LIGHT.
Other Precautions:NONE

Exposure Controls

Respiratory Protection:NONE REQUIRED
Ventilation:NO SPECIAL PROVISIONS REQUIRED.
Protective Gloves:IMPERVIOUS
Eye Protection:SAFETY GLASSES
Other Protective Equipment:MFR GAVE NO INFORMATION ON MSDS.
Work Hygienic Practices:MFR:?. HMIS:USE NORMAL MEDICAL (HOSPITAL)
HYGIENE PRACTICES. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
NONE

Chemical Properties

HCC:T6
NRC/State Lic Num:NONE
Boiling Pt:B.P. Text:212F,100C
Melt/Freeze Pt:M.P/F.P Text:32.0F,0.0C
Spec Gravity:1.00
pH:2.5-6
Solubility in Water:AQUEOUS SOLUTION
Appearance and Odor:CLEAR LIQUID
Percent Volatiles by Volume:NEGL.

Stability

Stability Indicator/Materials to Avoid:YES
ALKALIES,TANNIC ACID,IODIC ACID,POTASSIUM
PERMANGATE,BORAX,CHLORATES,FERRIC CHLORIDE,IODIDES,LEAD
ACETATE,MAGNESIA,HGHCL
Stability Condition to Avoid:EXPOSURE TO LIHGHT & HIGH TEMPERATURES.
Hazardous Decomposition Products:WHEN HEATED TO DECOMPOSITION, EMITS
NOX.
Conditions to Avoid Polymerization:MFR GAVE NO INFORMATION ON MSDS.

Disposal

Waste Disposal Methods:DISPOSE OF SOLUTION IN SEWER. BURY IN LANDFILL.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.